ESRRA and breast carcinoma: Figure 1D,E showed that ERRα expression and protein levels were remarkably enhanced within BT-474R cell lines than those within parental BT-474 cell lines, indicating that ERRα might be a key factor in breast cancer cell resistance to lapatinib.